Mitochondrial Dysfunction, Oxidative Stress, and Inter-Organ Miscommunications in T2D Progression
International Journal of Molecular Sciences · 25.01.2024 · 25 (3) · 1504
DOI: 10.3390/ijms25031504 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 25.01.2024. Verfasst von Rajakrishnan Veluthakal und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular and Cellular Endocrinology, Arthur Riggs Diabetes & Metabolism Research Institute, City of Hope Beckman Research Institute, 1…. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Prediabetic State, Insulin Resistance, Mitochondrial Diseases. Die Arbeit wurde bisher 90-mal zitiert (Crossref) und nennt 242 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, NIH HHS, Breakthrough T1D.
Abstract (Originalsprache)
Type 2 diabetes (T2D) is a heterogenous disease, and conventionally, peripheral insulin resistance (IR) was thought to precede islet β-cell dysfunction, promoting progression from prediabetes to T2D. New evidence suggests that T2D-lean individuals experience early β-cell dysfunction without significant IR. Regardless of the primary event (i.e., IR vs. β-cell dysfunction) that contributes to dysglycemia, significant early-onset oxidative damage and mitochondrial dysfunction in multiple metabolic tissues may be a driver of T2D onset and progression. Oxidative stress, defined as the generation of reactive oxygen species (ROS), is mediated by hyperglycemia alone or in combination with lipids. Physiological oxidative stress promotes inter-tissue communication, while pathological oxidative stress promotes inter-tissue mis-communication, and new evidence suggests that this is mediated via extracellular vesicles (EVs), including mitochondria containing EVs. Under metabolic-related stress conditions, EV-mediated cross-talk between β-cells and skeletal muscle likely trigger mitochondrial anomalies leading to prediabetes and T2D. This article reviews the underlying molecular mechanisms in ROS-related pathogenesis of prediabetes, including mitophagy and mitochondrial dynamics due to oxidative stress. Further, this review will describe the potential of various therapeutic avenues for attenuating oxidative damage, reversing prediabetes and preventing progression to T2D.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Molecular and Cellular Endocrinology, Arthur Riggs Diabetes & Metabolism Research Institute, City of Hope Beckman Research Institute, 1500 E. Duarte Rd, Duarte, CA 91010, USA.
ORCID-Profile: Rajakrishnan Veluthakal, Joseph M Hoolachan, Rekha Balakrishnan, Eunjin Oh, Chathurani S Jayasena
Förderung
- NIDDK NIH HHS
- NIH HHS
- Breakthrough T1D
- National Institutes of Health
- Juvenile Diabetes Research Foundation
- American Heart Association
- Ford Foundation
- Wanek Project to Cure Type 1 Diabetes at the City of Hope
Zitieren
APA
Veluthakal, R., Esparza, D., Hoolachan, J. M., Balakrishnan, R., Ahn, M., Oh, E., Jayasena, C. S., & Thurmond, D. C. (2024). Mitochondrial Dysfunction, Oxidative Stress, and Inter-Organ Miscommunications in T2D Progression. International Journal of Molecular Sciences, 25(3), 1504. https://doi.org/10.3390/ijms25031504
Vancouver
Veluthakal R, Esparza D, Hoolachan JM, Balakrishnan R, Ahn M, Oh E, et al. Mitochondrial Dysfunction, Oxidative Stress, and Inter-Organ Miscommunications in T2D Progression. International Journal of Molecular Sciences. 2024;25(3):1504. doi:10.3390/ijms25031504
BibTeX
@article{Veluthakal2024,
author = {Veluthakal, Rajakrishnan and Esparza, Diana and Hoolachan, Joseph M and Balakrishnan, Rekha and Ahn, Miwon and Oh, Eunjin and Jayasena, Chathurani S and Thurmond, Debbie C},
title = {Mitochondrial Dysfunction, Oxidative Stress, and Inter-Organ Miscommunications in T2D Progression},
journal = {International Journal of Molecular Sciences},
year = {2024},
volume = {25},
number = {3},
pages = {1504},
doi = {10.3390/ijms25031504}
}
EUVIMED